Page last updated: 2024-08-23

dihydroxyethyldithiocarbamate and Congenital Hypocupremia

dihydroxyethyldithiocarbamate has been researched along with Congenital Hypocupremia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujisawa, C; Gu, YH; Kodama, H; Kozuma, T; Sato, E; Shiga, K1

Other Studies

1 other study(ies) available for dihydroxyethyldithiocarbamate and Congenital Hypocupremia

ArticleYear
Effect of copper and diethyldithiocarbamate combination therapy on the macular mouse, an animal model of Menkes disease.
    Journal of inherited metabolic disease, 2005, Volume: 28, Issue:6

    Topics: Animals; Body Weight; Brain; Catecholamines; Chelating Agents; Copper; Disease Models, Animal; Ditiocarb; Dopamine beta-Hydroxylase; Electron Transport Complex IV; Humans; Kidney; Lipids; Liver; Male; Menkes Kinky Hair Syndrome; Metal Metabolism, Inborn Errors; Mice; Mice, Mutant Strains; Models, Statistical

2005